GINA BENNETT: Open Payments
NPI 1760095137 · IONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 21 payments from 11 companies in 2025. Trend: 2023 $75 · 2024 $626 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $135 |
| ABBVIE INC. | 6 | $120 |
| Novo Nordisk Inc | 1 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Corium, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: CAPLYTA, Ozempic, MAVYRET, VRAYLAR, BREZTRI, FARXIGA, REXULTI, Azstarys.
Industry payments across MI — which companies pay providers there.
